{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T16:06:45Z","timestamp":1709395605572},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T00:00:00Z","timestamp":1599782400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T00:00:00Z","timestamp":1599782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>To test the hypothesis of washout from the anterior pituitary (AP) gland after serial injections of gadodiamide. We included 59 patients with history of at least 5 injections of gadodiamide. Values of mean signal intensity of the AP and of the central pons were measured on unenhanced sagittal T1-weighted images. AP-to-pons signal intensity ratios were calculated dividing the values of the AP by those of the pons. The measurements were performed using MR images acquired at four different time points including baseline (prior to any gadodiamide injection), minimum post-injection time delay, maximum post-injection time delay, and last available MR scans. Normalized ratios (i.e. ratios divided total volume of injected gadodiamide) were also calculated. To assess the difference between ratios, non-parametric Wilcoxon signed-rank test was applied. The correlations were tested with non-parametric Spearman correlation coefficient. A p-value\u2009&lt;\u20090.05 was considered as statistically significant. A statistically significant increase of AP signal intensity was found by comparing the baseline scans with both the minimum time delay (p\u2009=\u20090.003) and maximum time delay scans (p\u2009=\u20090.005). We found significant higher normalized ratios for minimum post-injection time delay with respect to maximum post-injection time delay (p\u2009&lt;\u20090.001). The normalized ratios demonstrated a statistically significant negative correlation with the post-injection time delay (r\u2009= \u2212 0.31; p\u2009=\u20090.006). The findings of this study suggest that washout phenomena of retained\/deposited gadolinium from the AP are influenced by the total injected volume and post-injection time delay.<\/jats:p>","DOI":"10.1038\/s41598-020-71981-0","type":"journal-article","created":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T10:09:21Z","timestamp":1599818961000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Anterior pituitary gland T1 signal intensity is influenced by time delay after injection of gadodiamide"],"prefix":"10.1038","volume":"10","author":[{"given":"Carlo A.","family":"Mallio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Messina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Parillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianguido","family":"Lo Vullo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Beomonte Zobel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul M.","family":"Parizel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo C.","family":"Quattrocchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,11]]},"reference":[{"key":"71981_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1152\/physrev.00003.2011","volume":"92","author":"C Perez-Castro","year":"2012","unstructured":"Perez-Castro, C., Renner, U., Haedo, M. R., Stalla, G. K. & Arzt, E. Cellular and molecular specificity of pituitary gland physiology. Physiol. Rev. 92, 1\u201338 (2012).","journal-title":"Physiol. Rev."},{"key":"71981_CR2","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1097\/00004728-198905000-00002","volume":"13","author":"PM Parizel","year":"1989","unstructured":"Parizel, P. M. et al. Gadolinium-DOTA enhanced MR imaging of intracranial lesions. J. Comput. Assist. Tomogr. 13, 378\u2013385 (1989).","journal-title":"J. Comput. Assist. Tomogr."},{"key":"71981_CR3","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.18388\/abp.2000_3963","volume":"47","author":"A Palasz","year":"2000","unstructured":"Palasz, A. & Czekaj, P. Toxicological and cytophysiological aspects of lanthanides action. Acta Biochim. Pol. 47, 1107\u20131114 (2000).","journal-title":"Acta Biochim. Pol."},{"key":"71981_CR4","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1148\/radiol.2015150697","volume":"277","author":"T Kanda","year":"2015","unstructured":"Kanda, T., Matsuda, M., Oba, H., Toyoda, K. & Furui, S. Gadolinium deposition after contrast-enhanced MR imaging. Radiology 277, 924\u2013925 (2015).","journal-title":"Radiology"},{"key":"71981_CR5","doi-asserted-by":"publisher","first-page":"944","DOI":"10.3174\/ajnr.A6586","volume":"41","author":"CA Mallio","year":"2020","unstructured":"Mallio, C. A., Quattrocchi, C. C., Rovira, \u00c0 & Parizel, P. M. Gadolinium deposition safety: Seeking the patient\u2019s perspective. AJNR Am. J. Neuroradiol. 41, 944\u2013946 (2020).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"71981_CR6","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1148\/radiol.2017161595","volume":"285","author":"RJ McDonald","year":"2017","unstructured":"McDonald, R. J. et al. Gadolinium deposition in human brain tissues after contrast-enhanced MR imaging in adult patients without intracranial abnormalities. Radiology 285, 546\u2013554 (2017).","journal-title":"Radiology"},{"key":"71981_CR7","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s00234-020-02434-8","volume":"62","author":"CA Mallio","year":"2020","unstructured":"Mallio, C. A., Rovira, \u00c0, Parizel, P. M. & Quattrocchi, C. C. Exposure to gadolinium and neurotoxicity: current status of preclinical and clinical studies. Neuroradiology 62, 925\u2013934 (2020).","journal-title":"Neuroradiology"},{"key":"71981_CR8","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1148\/radiol.2015150464","volume":"276","author":"CC Quattrocchi","year":"2015","unstructured":"Quattrocchi, C. C., Mallio, C. A., Errante, Y. & Beomonte Zobel, B. High T1 signal intensity in dentate nucleus after multiple injections of linear gadolinium chelates. Radiology 276, 616\u2013617 (2015).","journal-title":"Radiology"},{"key":"71981_CR9","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1148\/radiol.2018182349","volume":"290","author":"CA Mallio","year":"2019","unstructured":"Mallio, C. A., Ramalho, J. & Quattrocchi, C. C. Impact of brain irradiation, chemotherapy, and presence of primary brain tumors on changes in signal intensity after exposure to gadolinium-based contrast agents. Radiology 290, 575\u2013576 (2019).","journal-title":"Radiology"},{"key":"71981_CR10","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1097\/RLI.0000000000000227","volume":"50","author":"A Radbruch","year":"2015","unstructured":"Radbruch, A. et al. High-signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted images: Evaluation of the macrocyclic gadolinium-based contrast agent gadobutrol. Invest. Radiol. 50, 805\u2013810 (2015).","journal-title":"Invest. Radiol."},{"key":"71981_CR11","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/RLI.0000000000000528","volume":"54","author":"M Parillo","year":"2019","unstructured":"Parillo, M. et al. A structured survey on adverse events occurring within 24 hours after intravenous exposure to gadodiamide or gadoterate meglumine: A controlled prospective comparison study. Invest. Radiol. 54, 191\u2013197 (2019).","journal-title":"Invest. Radiol."},{"key":"71981_CR12","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1097\/RLI.0000000000000431","volume":"53","author":"CC Quattrocchi","year":"2018","unstructured":"Quattrocchi, C. C. et al. Effect of age on high T1 signal intensity of the dentate nucleus and globus pallidus in a large population exposed to gadodiamide. Invest. Radiol. 53, 214\u2013222 (2018).","journal-title":"Invest. Radiol."},{"key":"71981_CR13","doi-asserted-by":"crossref","unstructured":"Guo, B. J., Yang, Z. L., Zhang, L.J. Gadolinium deposition in brain: Current scientific evidence and future perspectives. Front. Mol. Neurosci. 20(11), 335 (2018).","DOI":"10.3389\/fnmol.2018.00335"},{"key":"71981_CR14","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3348\/kjr.2018.0356","volume":"20","author":"JW Choi","year":"2019","unstructured":"Choi, J. W. & Moon, W. J. Gadolinium deposition in the brain: Current updates. Korean J. Radiol. 20, 134\u2013147 (2019).","journal-title":"Korean J. Radiol."},{"key":"71981_CR15","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/jon.12448","volume":"27","author":"P Eisele","year":"2017","unstructured":"Eisele, P. et al. Sodium MRI of T1 high signal intensity in the dentate nucleus due to gadolinium deposition in multiple sclerosis. J. Neuroimaging. 27, 372\u2013375 (2017).","journal-title":"J. Neuroimaging."},{"key":"71981_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mri.2019.01.007","volume":"58","author":"P Eisele","year":"2019","unstructured":"Eisele, P. et al. Diffusion-weighted imaging of the dentate nucleus after repeated application of gadolinium-based contrast agents in multiple sclerosis. Magn. Reson. Imaging. 58, 1\u20135 (2019).","journal-title":"Magn. Reson. Imaging."},{"key":"71981_CR17","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/jmri.26669","volume":"50","author":"CA Mallio","year":"2019","unstructured":"Mallio, C. A. et al. Absence of dentate nucleus resting-state functional connectivity changes in nonneurological patients with gadolinium-related hyperintensity on T1-weighted images. J. Magn. Reson. Imaging. 50, 445\u2013455 (2019).","journal-title":"J. Magn. Reson. Imaging."},{"key":"71981_CR18","doi-asserted-by":"publisher","first-page":"e611","DOI":"10.1212\/WNL.0000000000007892","volume":"93","author":"R Zivadinov","year":"2019","unstructured":"Zivadinov, R. et al. Cumulative gadodiamide administration leads to brain gadolinium deposition in early MS. Neurology. 93, e611\u2013e623 (2019).","journal-title":"Neurology."},{"key":"71981_CR19","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1002\/jmri.26948","volume":"51","author":"J Vymazal","year":"2020","unstructured":"Vymazal, J., Kr\u00e1msk\u00e1, L., Bro\u017eov\u00e1, H., R\u016f\u017ei\u010dka, E. & Rulseh, A. M. Does serial administration of gadolinium-based contrast agents affect patient neurological and neuropsychological status? Fourteen-year follow-up of patients receiving more than fifty contrast administrations. J. Magn. Reson. Imaging. 51, 1912\u20131913 (2020).","journal-title":"J. Magn. Reson. Imaging."},{"key":"71981_CR20","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s00234-020-02415-x","volume":"62","author":"CA Mallio","year":"2020","unstructured":"Mallio, C. A. et al. Within-network brain connectivity in Crohn\u2019s disease patients with gadolinium deposition in the cerebellum. Neuroradiology 62, 833\u2013841 (2020).","journal-title":"Neuroradiology"},{"key":"71981_CR21","doi-asserted-by":"publisher","unstructured":"Mallio, C. A., Parillo, M., Zobel, B. B, Parizel, P. M., Quattrocchi, C. C. Effect of exposure to gadodiamide and brain irradiation on T1-weighted images and ADC maps of the dentate nucleus. J. Magn. Reson. Imaging. https:\/\/doi.org\/10.1002\/jmri.27198 (2020)","DOI":"10.1002\/jmri.27198"},{"key":"71981_CR22","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/RLI.0000000000000344","volume":"52","author":"J Lohrke","year":"2017","unstructured":"Lohrke, J. et al. Histology and gadolinium distribution in the rodent brain after the administration of cumulative high doses of linear and macrocyclic gadolinium-based contrast agents. Invest. Radiol. 52, 324\u2013333 (2017).","journal-title":"Invest. Radiol."},{"key":"71981_CR23","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00401-018-1857-4","volume":"136","author":"S Fingerhut","year":"2018","unstructured":"Fingerhut, S. et al. Gadolinium-based contrast agents induce gadolinium deposits in cerebral vessel walls, while the neuropil is not affected: An autopsy study. Acta Neuropathol. 136, 127\u2013138 (2018).","journal-title":"Acta Neuropathol."},{"key":"71981_CR24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/RLI.0000000000000604","volume":"55","author":"CA Mallio","year":"2020","unstructured":"Mallio, C. A. et al. Increased T1 signal intensity of the anterior pituitary gland on unenhanced magnetic resonance images after chronic exposure to gadodiamide. Invest. Radiol. 55, 25\u201329 (2020).","journal-title":"Invest. Radiol."},{"key":"71981_CR25","doi-asserted-by":"crossref","unstructured":"El-Khatib, A. H. et al. Gadolinium in human brain sections and colocalization with other elements. Neurology: Neuroimmunol. NeuroInflamm. 6, e515 (2019).","DOI":"10.1212\/NXI.0000000000000515"},{"key":"71981_CR26","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1097\/RLI.0000000000000575","volume":"54","author":"A Radbruch","year":"2019","unstructured":"Radbruch, A. et al. Gadolinium deposition in the brain in a large animal model: Comparison of linear and macrocyclic gadolinium-based contrast agents. Invest. Radiol. 54, 531\u2013536 (2019).","journal-title":"Invest. Radiol."},{"key":"71981_CR27","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1148\/radiol.2019190461","volume":"294","author":"O Minaeva","year":"2020","unstructured":"Minaeva, O. et al. Nonhomogeneous gadolinium retention in the cerebral cortex after intravenous administration of gadolinium-based contrast agent in rats and humans. Radiology 294, 377\u2013385 (2020).","journal-title":"Radiology"},{"key":"71981_CR28","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.neurad.2016.03.001","volume":"43","author":"MG \u00c7etin\u00e7akmak","year":"2016","unstructured":"\u00c7etin\u00e7akmak, M. G. et al. MRI-based evaluation of the factors leading to pituitary iron overload in patients with thalassemia major. J. Neuroradiol. 43, 297\u2013302 (2016).","journal-title":"J. Neuroradiol."},{"key":"71981_CR29","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ejrad.2006.11.016","volume":"62","author":"A Christoforidis","year":"2007","unstructured":"Christoforidis, A. et al. MRI for the determination of pituitary iron overload in children and young adults with \u03b2-thalassaemia major. Eur. J. Radiol. 62, 138\u2013142 (2007).","journal-title":"Eur. J. Radiol."},{"key":"71981_CR30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S1042-3680(02)00017-7","volume":"14","author":"AP Amar","year":"2003","unstructured":"Amar, A. P. & Weiss, M. H. Pituitary anatomy and physiology. Neurosurg. Clin. N. Am. 14, 11\u201323 (2003).","journal-title":"Neurosurg. Clin. N. Am."},{"key":"71981_CR31","unstructured":"Sadler, T. Langman\u2019s Medical Embryology. 8th edn. (Lippincott Williams & Wilkins, Philadelphia, 2000)."},{"key":"71981_CR32","unstructured":"Allen, M. B. The Pituitary: A Current Review (ed. Allen, M. B.) (Academic Press, New York, 1977)."},{"key":"71981_CR33","unstructured":"Aron, D., Findling, J., Tyrell, J. Basic and Clinical Endocrinology. 5th edn. (Appleton and Lange, Stamford, 1997)."},{"key":"71981_CR34","unstructured":"Tuchmann-Duplessis, H., Auroux, M., Haegel, P. Illustrated Human Embryology, Vol. III. (Springer, New York, 1977)."},{"key":"71981_CR35","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/RLI.0000000000000181","volume":"50","author":"P Robert","year":"2015","unstructured":"Robert, P. et al. T1-weighted hypersignal in the deep cerebellar nuclei after repeated administrations of gadolinium-based contrast agents in healthy rats: Difference between linear and macrocyclic agents. Invest. Radiol. 50, 473\u2013480 (2015).","journal-title":"Invest. Radiol."},{"key":"71981_CR36","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/RLI.0000000000000241","volume":"51","author":"P Robert","year":"2016","unstructured":"Robert, P. et al. Linear gadolinium-based contrast agents are associated with brain gadolinium retention in healthy rats. Invest. Radiol. 51, 73\u201382 (2016).","journal-title":"Invest. Radiol."},{"key":"71981_CR37","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1097\/RLI.0000000000000440","volume":"53","author":"J Boyken","year":"2018","unstructured":"Boyken, J., Frenzel, T., Lohrke, J., Jost, G. & Pietsch, H. Gadolinium accumulation in the deep cerebellar nuclei and globus pallidus after exposure to linear but not macrocyclic gadolinium-based contrast agents in a retrospective pig study with high similarity to clinical conditions. Invest. Radiol. 53, 278\u2013285 (2018).","journal-title":"Invest. Radiol."},{"key":"71981_CR38","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2463\/mrms.rev.2017-0116","volume":"17","author":"T Taoka","year":"2018","unstructured":"Taoka, T. & Naganawa, S. Gadolinium-based contrast media, cerebrospinal fluid and the glymphatic system: Possible mechanisms for the deposition of gadolinium in the brain. Magn. Reson. Med. Sci. 17, 111\u2013119 (2018).","journal-title":"Magn. Reson. Med. Sci."},{"key":"71981_CR39","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/RLI.0000000000000533","volume":"54","author":"K Deike-Hofmann","year":"2019","unstructured":"Deike-Hofmann, K. et al. Glymphatic pathway of gadolinium-based contrast agents through the brain: Overlooked and misinterpreted. Invest. Radiol. 54, 229\u2013237 (2019).","journal-title":"Invest. Radiol."},{"key":"71981_CR40","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1007\/s00330-016-4654-2","volume":"27","author":"G Jost","year":"2017","unstructured":"Jost, G. et al. Penetration and distribution of gadolinium-based contrast agents into the cerebrospinal fluid in healthy rats: A potential pathway of entry into the brain tissue. Eur. Radiol. 27, 2877\u20132885 (2017).","journal-title":"Eur. Radiol."},{"key":"71981_CR41","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1002\/jmri.21969","volume":"30","author":"S Aime","year":"2009","unstructured":"Aime, S. & Caravan, P. Biodistribution of gadolinium-based contrast agents, including gadolinium deposition. J. Magn. Reson. Imaging. 30, 1259\u20131267 (2009).","journal-title":"J. Magn. Reson. Imaging."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-71981-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-71981-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-71981-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T18:53:14Z","timestamp":1670352794000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-71981-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,11]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["71981"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-71981-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,11]]},"assertion":[{"value":"27 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14967"}}